Furthermore, RT-qPCR showed that WNT5A mRNA levels were decreased in PC3-shESS2 cells (Fig. 5f), and a correlation was observed between ESS2 and WNT5A expression in patients with prostate cancer (Fig. 5g). The gene discussed is WNT5A; the disease is prostate carcinoma.